The most recent recall of Children's Tylenol and related products is "a matter of great concern," writes Johnson & Johnson CEO Bill Weldon on a company blog. In a sustained GMP embarrassment, the late April recall marks the fourth such Tylenol action in as many months. It follows the mid-March move of quality VP Veronica Cruz to McNeil from J&J, and it precedes McNeil's hiring of independent quality experts. That's a lot of QC horsepower rolling into May, the fifth month; hopefully it will forestall a fifth Tylenol recall. Blog | Item